Start a conversation.

Whether you are a laboratory evaluating the platform, an investor assessing the thesis, or a prospective collaborator — the fastest route is to say which and what you need.

Three routes.

Contact routes.
If you areWhat to ask forWhere
A laboratory evaluating the platformA technical walkthrough and an indicative cost range for your assay mixThree.Group
An investorThe thesis conversation; diligence material is shared under NDAInvestor overview → Three.Group
Press or an analystPositioning, the validation approach, and what we will not claimThree.Group

GenoAccel is a Three.Group platform, and enquiries route through Three.Group while the dedicated entity is being established. Owner note: replace this block with a real email address and postal address once they exist — a specific contact point also strengthens search-engine entity recognition, which is why it is flagged rather than invented here.